CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The eGreenchem project focuses on developing new nucleoside analogues through innovative electrochemical methods. By functionalizing the ribose moiety, it aims to create a library of compounds for potential drug development targeting unmet clinical needs in therapeutic applications.
Medicinal chemistry is a fast-evolving discipline.
Since the early 2000s is shifting its interest from a traditional small molecule's flat domain to a 3D molecular space that can address the ongoing demand for therapeutic solution targeting unmet clinical diseases.
In this context, during the last years new classes of compounds are being used as therapeutic agents; among them, DNA- and RNA-based therapeutics agents are gaining a prominent role in drug process development.
Natural nucleosides, t…
CHIESI FARMACEUTICI SPA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Netherlands, Amsterdam
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
